DF Dent & Co. Inc. Holds Stake in Colgate-Palmolive Company (NYSE:CL)
DF Dent & Co. Inc. maintained its position in Colgate-Palmolive Company (NYSE:CL) during the first quarter, Holdings Channel reports. The institutional investor owned 9,925 shares of the company’s stock at the end of the first quarter. DF Dent & Co. Inc.’s holdings in Colgate-Palmolive were worth $726,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of CL. AlphaMark Advisors LLC increased its stake in Colgate-Palmolive by 452.1% in the first quarter. AlphaMark Advisors LLC now owns 1,673 shares of the company’s stock worth $122,000 after buying an additional 1,370 shares during the last quarter. North Star Investment Management Corp. increased its stake in Colgate-Palmolive by 3.9% in the first quarter. North Star Investment Management Corp. now owns 1,797 shares of the company’s stock worth $132,000 after buying an additional 67 shares during the last quarter. Blue Chip Partners Inc. increased its stake in Colgate-Palmolive by 0.4% in the first quarter. Blue Chip Partners Inc. now owns 1,805 shares of the company’s stock worth $132,000 after buying an additional 8 shares during the last quarter. Advantage Investment Management LLC increased its stake in Colgate-Palmolive by 16.8% in the first quarter. Advantage Investment Management LLC now owns 1,850 shares of the company’s stock worth $135,000 after buying an additional 266 shares during the last quarter. Finally, Heritage Trust Co purchased a new stake in Colgate-Palmolive during the first quarter worth about $146,000. 73.85% of the stock is currently owned by institutional investors.
Colgate-Palmolive Company (NYSE:CL) traded down 0.35% during trading on Thursday, hitting $71.32. The stock had a trading volume of 324,764 shares. Colgate-Palmolive Company has a 12 month low of $63.43 and a 12 month high of $77.27. The company has a market cap of $62.82 billion, a PE ratio of 26.50 and a beta of 0.80. The company’s 50 day moving average is $73.08 and its 200-day moving average is $72.72.
Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, July 21st. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.72. The company had revenue of $3.83 billion during the quarter, compared to analysts’ expectations of $3.89 billion. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The firm’s quarterly revenue was down .5% compared to the same quarter last year. During the same quarter last year, the firm earned $0.70 earnings per share. On average, equities research analysts predict that Colgate-Palmolive Company will post $2.89 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, August 15th. Stockholders of record on Tuesday, July 18th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, July 14th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 2.24%. Colgate-Palmolive’s payout ratio is presently 59.48%.
WARNING: This piece was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was stolen and republished in violation of international copyright & trademark laws. The legal version of this piece can be viewed at https://www.watchlistnews.com/df-dent-co-inc-holds-stake-in-colgate-palmolive-company-nysecl/1470691.html.
A number of research firms have issued reports on CL. Zacks Investment Research downgraded Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Thursday, July 27th. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $74.00 price objective on shares of Colgate-Palmolive in a research note on Thursday, May 25th. UBS AG reaffirmed a “neutral” rating and issued a $78.00 price objective (down previously from $79.00) on shares of Colgate-Palmolive in a research note on Tuesday, May 2nd. BidaskClub downgraded Colgate-Palmolive from a “sell” rating to a “strong sell” rating in a research note on Wednesday, July 12th. Finally, Jefferies Group LLC reaffirmed a “hold” rating and issued a $79.00 price objective (up previously from $77.00) on shares of Colgate-Palmolive in a research note on Monday, July 24th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the stock. The stock has an average rating of “Hold” and a consensus price target of $75.82.
In other news, COO Justin Skala sold 74,374 shares of Colgate-Palmolive stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the sale, the chief operating officer now directly owns 97,177 shares of the company’s stock, valued at $7,046,304.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, insider Patricia Verduin sold 3,833 shares of Colgate-Palmolive stock in a transaction on Monday, July 17th. The shares were sold at an average price of $72.41, for a total value of $277,547.53. Following the completion of the sale, the insider now directly owns 53,022 shares of the company’s stock, valued at $3,839,323.02. The disclosure for this sale can be found here. Insiders sold 203,969 shares of company stock valued at $14,711,068 over the last ninety days. Insiders own 1.02% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related companies with Analyst Ratings Network's FREE daily email newsletter.